45 related articles for article (PubMed ID: 20381119)
1. Ki-67 labeling index and Knosp classification of pituitary adenomas.
Yuhan L; Zhiqun W; Jihui T; Renlong P
Br J Neurosurg; 2024 Apr; 38(2):393-397. PubMed ID: 33905276
[TBL] [Abstract][Full Text] [Related]
2. TNF-α can promote membrane invasion by activating the MAPK/MMP9 signaling pathway through autocrine in bone-invasive pituitary adenoma.
Wu X; Gong L; Li B; Bai J; Li C; Zhang Y; Zhu H
CNS Neurosci Ther; 2024 May; 30(5):e14749. PubMed ID: 38739004
[TBL] [Abstract][Full Text] [Related]
3. Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells.
del Pliego MG; Aguirre-Benítez E; Paisano-Cerón K; Valdovinos-Ramírez I; Rangel-Morales C; Rodríguez-Mata V; Solano-Agama C; Martín-Tapia D; de la Vega MT; Saldoval-Balanzario M; Camacho J; Mendoza-Garrido ME
Int J Clin Exp Pathol; 2013; 6(3):458-68. PubMed ID: 23413122
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.
Papadimitriou E; Chatzellis E; Dimitriadi A; Kaltsas GA; Theocharis S; Alexandraki KI
touchREV Endocrinol; 2023 Nov; 19(2):42-53. PubMed ID: 38187082
[TBL] [Abstract][Full Text] [Related]
5. Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.
Serioli S; Agostini L; Pietrantoni A; Valeri F; Costanza F; Chiloiro S; Buffoli B; Piazza A; Poliani PL; Peris-Celda M; Iavarone F; Gaudino S; Gessi M; Schinzari G; Mattogno PP; Giampietro A; De Marinis L; Pontecorvi A; Fontanella MM; Lauretti L; Rindi G; Olivi A; Bianchi A; Doglietto F
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958702
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of Blood Markers in Nonfunctional Pituitary Adenomas using Artificial Neural Network.
Sayyadi S; Kashani HRK; Jafari R; Azhari S; Salimi S; Komlakh K; Alesaadi M; Alizade P; Solomon H; Khayatkashani M
Adv Biomed Res; 2023; 12():83. PubMed ID: 37200767
[TBL] [Abstract][Full Text] [Related]
7. The Pituitary Tumors and Their Tumor-Specific Microenvironment.
Kameda-Smith MM; Lu J-
Adv Exp Med Biol; 2020; 1296():117-135. PubMed ID: 34185289
[TBL] [Abstract][Full Text] [Related]
8. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
[TBL] [Abstract][Full Text] [Related]
9. Molecular Network Basis of Invasive Pituitary Adenoma: A Review.
Yang Q; Li X
Front Endocrinol (Lausanne); 2019; 10():7. PubMed ID: 30733705
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro.
Zhou K; Fan YD; Wu PF; Duysenbi S; Feng ZH; Du GJ; Zhang TR
Onco Targets Ther; 2017; 10():1625-1635. PubMed ID: 28352194
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.
Liu HY; Gu WJ; Wang CZ; Ji XJ; Mu YM
Medicine (Baltimore); 2016 Jun; 95(24):e3904. PubMed ID: 27310993
[TBL] [Abstract][Full Text] [Related]
12. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
13. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 in pituitary neoplasms: a review--part I.
Salehi F; Agur A; Scheithauer BW; Kovacs K; Lloyd RV; Cusimano M
Neurosurgery; 2009 Sep; 65(3):429-37; discussion 437. PubMed ID: 19687686
[TBL] [Abstract][Full Text] [Related]
15. Predictive markers of pituitary adenoma behavior.
Kontogeorgos G
Neuroendocrinology; 2006; 83(3-4):179-88. PubMed ID: 17047381
[TBL] [Abstract][Full Text] [Related]
16. CD147 expression in pituitary adenomas and its significance for clinical outcome.
Qu X; Yang W; Jiang M; Han T; Han L; Qu Y; Wang G; Shi D; Xu G
Hum Pathol; 2010 Aug; 41(8):1165-71. PubMed ID: 20381119
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.
Liu W; Kunishio K; Matsumoto Y; Okada M; Nagao S
J Clin Neurosci; 2005 Sep; 12(7):791-4. PubMed ID: 16198918
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
